Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Semin Arthritis Rheum. 2022 Sep 17;57:152098. doi: 10.1016/j.semarthrit.2022.152098

Table 1.

Characteristics of study population at registry enrollment by interstitial lung disease (ILD) status.

N Total
(N=2561)
RA-ILD
(N=238)
RA no-ILD
(N=2323)
p value
Age, years 2560 69.4 (10.8) 72.0 (9.0) 69.2 (10.9) <0.001
Male sex, n (%) 2557 2275 (89.0) 225 (94.5) 2050 (88.4) 0.004
Race and ethnicity, n (%) 2556 0.36
Black/African American 417 (16.3) 44 (18.5) 373 (16.1)
White 1962 (76.7) 174 (73.1) 1788 (77.1)
Other* 177 (6.9) 20 (8.4) 157 (6.8)
BMI category, n (%) 2545 0.73
Underweight (<20 kg/m2) 84 (3.3) 6 (2.5) 78 (3.4)
Normal (20-24.9 kg/m2) 479 (18.8) 50 (21.2) 429 (18.6)
Overweight (25-29.9 kg/m2) 920 (36.1) 84 (35.6) 836 (36.2)
Obese (>30 kg/m2) 1062 (41.7) 96 (40.7) 966 (41.8)
Smoking history (ever), n (%) 2560 1989 (77.7) 204 (85.7) 1785 (76.9) 0.002
RA disease duration, years 2507 10.1 (11.2) 11.1 (12.1) 10.0 (11.2) 0.42
Anti-CCP positive, n (%) 2419 1874 (77.5) 192 (84.2) 1682 (76.8) 0.01
DAS28 2522 3.23 (1.08) 3.48 (1.10) 3.21 (1.07) <0.001

Values mean (SD) unless otherwise noted. P values by chi-square or independent t-test.

*

Other includes Asian American, American Indian/Pacific Islander, and Hispanic.

BMI = body mass index; Anti-CCP = anti-cyclic citrullinated protein antibody; DAS-28 = disease activity score (28 joints).